Bupivacaine (USAN:INN:BAN)
Specifications
2180-92-9CAS Number
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamideIUPAC Name
C18H28N2OChemical Formula
288.4 g/molMolecular Weight
Bupivacaine [USAN:INN:BAN]; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-; Bupivacaine (USAN:INN:BAN); RefChem:1080208; bupivacaine; 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; 2180-92-9; 38396-39-3; DL-Bupivacaine; Bupivacaina; Anekain; (+-)-Bupivacaine; Bupivacainum; 1-Butyl-2',6'-pipecoloxylidide; Bupivacainum [INN-Latin]; Bupivacaina [INN-Spanish]; dl-1-Butyl-2',6'-pipecoloxylidide; Exparel; (+/-)-Bupivacaine; AH 250; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-; Win 11318; Bloqueina; 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide; Posimir; SKY0402; 2',6'-Pipecoloxylidide, 1-butyl-; 1-butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide; LIQ865; Bupivan; BR-003; Y8335394RO; cBupivacaine; Bupivacaine HCL KIT; bucain; Bucaine; Bucaine (TN); DUR-843; EINECS 218-553-3; EINECS 253-911-2; Bloccoc; Svedocain; Nocita; Carbostesin;; Sensorcaine;; Bloqueina;; Duracaine;; Marcaine;; Meaverin-ultra;; RS-Bupivacaine; Narcain;; UNII-Y8335394RO; HSDB 7790; racemic bupivacaine; (RS)-bupivacaine; Bupivacaina (base); Bupivacaine liposome; SKY 0402; Exparel (TN); Liposomal bupivacaine; Spectrum_001524; (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; Bupivacaine liposome injectable suspension; 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride hydrate; BUPIVACAINE [MI]; Prestwick0_000305; Prestwick1_000305; Prestwick2_000305; Prestwick3_000305; Spectrum2_001589; Spectrum3_000974; Spectrum4_001098; Spectrum5_001483; BUPIVACAINE [INN]; (.+/-.)-1-Butyl-2',6'-pipecoloxylidide; (.+/-.)-Bupivacaine; Bupivacaine (USAN/INN); BUPIVACAINE [HSDB]; BUPIVACAINE [USAN]; LAC-43 (Salt/Mix); Epitope ID:122662; WIN-11318 free base; BUPIVACAINE [VANDF]; Bupivacaine [EP monograph]; Marcaine spinal (Salt/Mix); CHEMBL1098; SCHEMBL25438; BSPBio_000270; BSPBio_002607; BUPIVACAINE [WHO-DD]; KBioGR_001516; KBioSS_002004; DivK1c_000758; SPBio_001558; SPBio_002489; Bupivacaine; (RS)-bupivacaine; BPBio1_000298; CHEBI:3215; GTPL2397; orb1710763; orb2901855; BUPIVACAINE [GREEN BOOK]; DTXSID2022703; CHEBI:77431; KBio1_000758; KBio2_002004; KBio2_004572; KBio2_007140; KBio3_001827; BUPIVACAINE [ORANGE BOOK]; LIQ-865; NINDS_000758; HMS2090F12; HMS3428P06; HMS5086P18; Marcaine hydrochloride (Salt/Mix); HY-B0405; MSK11353; SKY-0402; BDBM50350790; EBC-04397; MFCD00243007; MFCD00941462; s5181; T0030L; ZYNRELEF COMPONENT BUPIVACAINE; AKOS001637202; AKOS016842516; MSK11353-100A; AC-2096; BS-5224; CS-W023182; DB00297; FB61551; IDI1_000758; NCGC00178579-01; NCGC00178579-02; NCGC00178579-12; BB166160; ST065773; SBI-0051846.P002; DB-119016; AB00053674; B8261; NS00000609; Bupivacaine Solution in Acetonitrile, 100ug/mL; C07529; D07552; Ropivacaine hydrochloride impurity, bupivacaine-; AB00053674-08; AB00053674-09; AB00053674_10; AB00053674_11; EN300-18292932; L000695; Q422806; BRD-A01636364-003-05-2; BRD-A01636364-003-08-6; BRD-A01636364-003-14-4; BRD-A01636364-003-15-1; F2173-1162; N-(2,6-dimethylphenyl)(1-butyl(2-piperidyl))carboxamide; 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboximidic acid; 1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboximidicAcid; (2RS)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide.; (plusmn)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; 1-Butyl-N-(2 pound not6-dimethylphenyl)piperidine-2-carboxamide; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+/-)-; 2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (.+/-.)-; ROPIVACAINE HYDROCHLORIDE IMPURITY, BUPIVACAINE- [USP IMPURITY]; 119427-31-5Synonyms
